1
Losartan and Uric Acid Metabolism in Children With Proteinuric Nephropathies
Condition(s):Uric Acid NephropathyLast Updated:November 28, 2022Recruiting
Losartan Potassium: 431 Clinical Trials, Page 1 of 44
Hide Studies Not Open or Pending
2
The Effects of Losartan on Social Reward
Condition(s):HealthyLast Updated:October 27, 2020Unknown status
3
A Bioequivalence Study of Losartan Potassium Tablets (Containing Losartan Potassium 100 mg) in Normal, Healthy, Adults Under Fasting Conditions
Condition(s):HealthyLast Updated:November 2, 2018Completed
4
Losartan for the Treatment of Pediatric NAFLD
Condition(s):NAFLD – Nonalcoholic Fatty Liver DiseaseLast Updated:October 21, 2021Terminated
5
Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease
Condition(s):Sickle Cell Disease; Diffuse Myocardial FibrosisLast Updated:March 13, 2023Recruiting
6
Losartan for Sickle Cell Kidney Disease
Condition(s):Sickle Cell DiseaseLast Updated:July 17, 2017Completed
7
An Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE)
Condition(s):Eosinophilic EsophagitisLast Updated:September 9, 2020Completed
8
Losartan and Emotion Processing
Condition(s):HealthyLast Updated:June 6, 2018Unknown status
9
Study of Open Label Losartan in COVID-19
Condition(s):COVID-19Last Updated:May 10, 2021Completed
10
Nighttime Losartan in Continous Ambulatory Peritoneal Dialysis (NVCAPD)
Condition(s):Hypertension,NephropathyLast Updated:November 5, 2018Not yet recruiting